J9144
HCPCSDaratumumab, hyaluronidase
Official HCPCS Level II long descriptor
Injection, daratumumab, 10 mg and hyaluronidase-fihj
HCPCS Level II code J9144 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Daratumumab, hyaluronidase
Added to HCPCS: 2021-01-01
Nearby codes in J9
- J9074Inj, cyclophosphamd, sandoz
- J9075Inj, cyclophosphamide, nos
- J9076Inj, cyclophos (baxter) 5mg
- J9100Cytarabine hcl 100 mg inj
- J9118Inj. calaspargase pegol-mknl
- J9119Inj., cemiplimab-rwlc, 1 mg
- J9120Dactinomycin injection
- J9130Dacarbazine 100 mg inj
- J9145Injection, daratumumab 10 mg
- J9150Daunorubicin injection
- J9153Inj daunorubicin, cytarabine
- J9155Degarelix injection
- J9161Inj denileuk difti-cxdl 1mcg
- J9171Docetaxel injection
- J9172Docetaxel (docivyx), 1 mg
- J9173Inj., durvalumab, 10 mg
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.